Image

3D Printed Breast Models in the Surgical Management of Breast Cancer

3D Printed Breast Models in the Surgical Management of Breast Cancer

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

To learn if providing a 3-D printed model of the breast can help breast cancer patients make decisions related to their care. During this study, some study participants will receive the 3-D printed model and some study participants will receive traditional breast imaging scans to learn if the 3-D printed model

Description

Primary Objective:

•The objective of this prospective study is to determine the impact of 3D printed breast models, compared to 2D imaging, on breast cancer patients' decisional conflict related to treatment decision-making.

Secondary Objective:

  • To observe if patients will change their initial desired surgical option (mastectomy versus lumpectomy) after viewing the 3D printed models
  • To evaluate the quality of the communication between surgical providers and patients with and without the 3D printed models
  • To assess the surgical outcome including the margin status
  • To evaluate patient satisfaction and well-being post-surgery between the 3D printed model group and the control group as well as mastectomy versus lumpectomy subgroups
  • To assess surgical providers' response to the acceptability and utility of the model

Eligibility

Inclusion Criteria:

  • Age 18 or older female
  • Patient must have histologically confirmed breast malignancy
  • Patient is a candidate for surgical management
  • Patient has a surgeon at MDACC (main campus and/or Houston Area Locations)
  • Patient has a breast MRI for extent of disease assessment at MDACC (main campus and/or Houston Area Locations).
  • Patient is able to speak, read or write English
  • Patient is willing to be randomized to the control or 3D printed breast model groups and is willing to sign the consent form.

Exclusion Criteria:

  • Pregnant and breastfeeding patients
  • Patients who had history of mastectomy, have recurrent malignancies on the mastectomy side
  • Patients for whom it is not feasible to create a 3D printed breast model from breast MRI

Study details
    Breast Cancer

NCT05755984

M.D. Anderson Cancer Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.